StockNews.AI
GILD
StockNews.AI
189 days

Gilead Sciences Announces 2.6 Percent Increase in First Quarter 2025 Dividend

1. Gilead's Board increased the quarterly dividend by 2.6%. 2. New dividend will be $0.79 per share starting Q1 2025. 3. Dividend payment is scheduled for March 28, 2025. 4. Future dividends will require Board approval. 5. Gilead continues to advance innovative medicines globally.

3m saved
Insight
Article

FAQ

Why Bullish?

Dividend increases often signal financial health and confidence. Past examples show positive impacts on GILD stock.

How important is it?

Dividend announcements are critical for investors looking for income. Gilead's commitment to returning value can boost investor sentiment.

Why Long Term?

Sustainable dividend increases can attract long-term investors. Historically, such moves foster investor loyalty and steady growth.

Related Companies

GILDABBVVRTX
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.6% in the company’s quarterly cash dividend, beginning in the first quarter of 2025. The increase will result in a quarterly dividend of $0.79 per share of common stock. The dividend is payable on March 28, 2025, to stockholders of record at the close of business on March 14, 2025. Future dividends will be subject to Board approval. About Gilead Sciences Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif. For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).

Related News